-
-
-
-
-
-
-
Goldman Sachs Upgrades Roche Holding (ROG:SW) (RHHBY) to Neutral
-
-
-
-
-
-
-
Genentech launches direct-to-patient program for flu drug Xofluza
-
-
-
-
-
-
-
Roche's (RHHBY) Genentech presents results from Phase 3 study of Lunsumio
-
-
-
-
-
-
-
Roche Holding (ROG:SW) (RHHBY) PT Raised to CHF265 at Deutsche Bank
-
-
-
-
-
-
-
Roche Holding (ROG:SW) (RHHBY) PT Raised to CHF290 at Berenberg
-
-
-
-
-
-
-
Roche hits 5-year lows on disappointing study results, JPMorgan's bearish comments
-
-
432,388 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

